SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-038736
Filing Date
2024-03-29
Accepted
2024-03-29 16:57:50
Documents
92
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cvsi-20231231.htm   iXBRL 10-K 2302845
2 EX-2.4 cvsi-ex2_4.htm EX-2.4 408201
3 EX-19.1 cvsi-ex19_1.htm EX-19.1 87411
4 EX-21.1 cvsi-ex21_1.htm EX-21.1 6605
5 EX-23.1 cvsi-ex23_1.htm EX-23.1 4529
6 EX-31.1 cvsi-ex31_1.htm EX-31.1 11734
7 EX-31.2 cvsi-ex31_2.htm EX-31.2 11991
8 EX-32.1 cvsi-ex32_1.htm EX-32.1 7405
9 EX-32.2 cvsi-ex32_2.htm EX-32.2 6906
  Complete submission text file 0000950170-24-038736.txt   11119029

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cvsi-20231231.xsd EX-101.SCH 1670861
96 EXTRACTED XBRL INSTANCE DOCUMENT cvsi-20231231_htm.xml XML 1742006
Mailing Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126
Business Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126 866-290-2157
CV Sciences, Inc. (Filer) CIK: 0001510964 (see all company filings)

IRS No.: 800944970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54677 | Film No.: 24804645
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)